107 related articles for article (PubMed ID: 27498210)
1. The impact of outpatient systemic anti-cancer treatment on patient costs and work practices.
Collins DC; Coghlan M; Hennessy BT; Grogan L; Morris PG; Breathnach OS
Ir J Med Sci; 2017 Feb; 186(1):81-87. PubMed ID: 27498210
[TBL] [Abstract][Full Text] [Related]
2. The cost of acute respiratory infections in Northern India: a multi-site study.
Peasah SK; Purakayastha DR; Koul PA; Dawood FS; Saha S; Amarchand R; Broor S; Rastogi V; Assad R; Kaul KA; Widdowson MA; Lal RB; Krishnan A
BMC Public Health; 2015 Apr; 15():330. PubMed ID: 25880910
[TBL] [Abstract][Full Text] [Related]
3. Economic disparities in treatment costs among ambulatory Medicaid cancer patients.
Mullins CD; Snyder SE; Wang J; Cooke JL; Baquet C
J Natl Med Assoc; 2004 Dec; 96(12):1565-74. PubMed ID: 15622686
[TBL] [Abstract][Full Text] [Related]
4. [Economic burden of cancer in China during 1996-2014: a systematic review].
Shi JF; Shi CL; Yue XP; Huang HY; Wang L; Li J; Lou PA; Mao AY; Dai M
Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):929-941. PubMed ID: 27998471
[No Abstract] [Full Text] [Related]
5. Treatment Costs of Breast Cancer Among Younger Women Aged 19-44 Years Enrolled in Medicaid.
Ekwueme DU; Allaire BT; Guy GP; Arnold S; Trogdon JG
Am J Prev Med; 2016 Feb; 50(2):278-85. PubMed ID: 26775907
[TBL] [Abstract][Full Text] [Related]
6. Expenditure audit of women with breast cancer in a tertiary care hospital of Delhi.
Pakseresht S; Ingle GK; Garg S; Singh MM
Indian J Cancer; 2011; 48(4):428-37. PubMed ID: 22293256
[TBL] [Abstract][Full Text] [Related]
7. The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system.
Bahia LR; Araujo DV; Schaan BD; Dib SA; Negrato CA; Leão MP; Ramos AJ; Forti AC; Gomes MB; Foss MC; Monteiro RA; Sartorelli D; Franco LJ
Value Health; 2011; 14(5 Suppl 1):S137-40. PubMed ID: 21839888
[TBL] [Abstract][Full Text] [Related]
8. Health economic burden of patients with restless legs syndrome in a German ambulatory setting.
Dodel R; Happe S; Peglau I; Mayer G; Wasem J; Reese JP; Giani G; Geraedts M; Trenkwalder C; Oertel WH; Stiasny-Kolster K
Pharmacoeconomics; 2010; 28(5):381-93. PubMed ID: 20297866
[TBL] [Abstract][Full Text] [Related]
9. Economic burden of cancer across the European Union: a population-based cost analysis.
Luengo-Fernandez R; Leal J; Gray A; Sullivan R
Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in healthcare expenditures among adults with diabetes: evidence from the medical expenditure panel survey, 2002-2011.
Williams JS; Bishu K; Dismuke CE; Egede LE
BMC Health Serv Res; 2017 Apr; 17(1):259. PubMed ID: 28399859
[TBL] [Abstract][Full Text] [Related]
11. Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.
Jönsen A; Hjalte F; Willim M; Carlsson KS; Sjöwall C; Svenungsson E; Leonard D; Bengtsson C; Rantapää-Dahlqvist S; Pettersson S; Gunnarsson I; Zickert A; Gustafsson JT; Rönnblom L; Petersson IF; Bengtsson AA; Nived O
Semin Arthritis Rheum; 2016 Jun; 45(6):684-90. PubMed ID: 26743074
[TBL] [Abstract][Full Text] [Related]
12. Economic burden of irritable bowel syndrome in China.
Zhang F; Xiang W; Li CY; Li SC
World J Gastroenterol; 2016 Dec; 22(47):10450-10460. PubMed ID: 28058026
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients.
Bennett CL; Calhoun EA
Oncologist; 2007 Apr; 12(4):478-83. PubMed ID: 17470690
[TBL] [Abstract][Full Text] [Related]
14. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
15. The economic burden of influenza-associated outpatient visits and hospitalizations in China: a retrospective survey.
Yang J; Jit M; Leung KS; Zheng YM; Feng LZ; Wang LP; Lau EH; Wu JT; Yu HJ
Infect Dis Poverty; 2015 Oct; 4():44. PubMed ID: 26445412
[TBL] [Abstract][Full Text] [Related]
16. Costs in Different States of Breast Cancer.
Roine E; Färkkilä N; Sintonen H; Taari K; Roine RP; Saarto T
Anticancer Res; 2019 Jan; 39(1):353-359. PubMed ID: 30591480
[TBL] [Abstract][Full Text] [Related]
17. The economic burden of metastatic breast cancer: a U.S. managed care perspective.
Montero AJ; Eapen S; Gorin B; Adler P
Breast Cancer Res Treat; 2012 Jul; 134(2):815-22. PubMed ID: 22684273
[TBL] [Abstract][Full Text] [Related]
18. Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison.
Neubauer S; Welte R; Beiche A; Koenig HH; Buesch K; Leidl R
Tob Control; 2006 Dec; 15(6):464-71. PubMed ID: 17130376
[TBL] [Abstract][Full Text] [Related]
19. Comparison of patient characteristics and gout-related health-care resource utilization and costs in patients with frequent versus infrequent gouty arthritis attacks.
Saseen JJ; Agashivala N; Allen RR; Ghushchyan V; Yadao AM; Nair KV
Rheumatology (Oxford); 2012 Nov; 51(11):2004-12. PubMed ID: 22829689
[TBL] [Abstract][Full Text] [Related]
20. Patient survival and healthcare utilization costs after diagnosis of triple-negative breast cancer in a United States managed care cancer registry.
Baser O; Wei W; Henk HJ; Teitelbaum A; Xie L
Curr Med Res Opin; 2012 Mar; 28(3):419-28. PubMed ID: 22364568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
